✦ LIBER ✦

Subconjunctival Palomid 529 in the treatment of neovascular age-related macular degeneration

✍ Scribed by Monica Dalal, Naima Jacobs-El…

Book ID: 120899464
Publisher: Springer-Verlag
Year: 2013
Tongue: English
Weight: 124 KB
Volume: 251
Category: Article
ISSN: 0065-6100
DOI: 10.1007/s00417-013-2375-7

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

VEGF inhibitors for the treatment of neo

VEGF inhibitors for the treatment of neovascular age-related macular degeneration

✍ Barakat, Mark Rami; Kaiser, PK 📂 Article 📅 2009 🏛 Informa plc 🌐 English ⚖ 306 KB

Age-related Macular Degeneration Diagnos

✍ Ho, Allen C.; Regillo, Carl D. 📂 Article 📅 2011 🏛 Springer New York 🌐 English ⚖ 930 KB

Age-Related Macular Degeneration: Diagnosis and Treatment is written by two leading experts from Wills Eye Hospital. Covering the latest therapies and treatments developed in the last few years, this is a concise yet highly illustrated and practical text that guides the clinician through diagnosis a

Canadian expert consensus: optimal treat

Canadian expert consensus: optimal treatment of neovascular age-related macular degeneration

✍ Cruess, Alan F.; Berger, Alan; Colleaux, Kevin; Greve, Mark; Harvey, Patricia; K 📂 Article 📅 2012 🏛 Canadian Ophthalmological Society 🌐 English ⚖ 623 KB

Predictors of anti-VEGF treatment respon

Predictors of anti-VEGF treatment response in neovascular age-related macular degeneration

✍ Finger, Robert P.; Wickremasinghe, Sanjeewa S.; Baird, Paul N.; Guymer, Robyn H. 📂 Article 📅 2014 🏛 Elsevier Science 🌐 English ⚖ 456 KB

Continued benefits of pegaptanib in neov

Continued benefits of pegaptanib in neovascular age-related macular degeneration

📂 Article 📅 2004 🏛 Adis International Limited (now part of Wolters Kl ⚖ 134 KB

Erratum: Canadian expert consensus: opti

Erratum: Canadian expert consensus: optimal treatment of neovascular age-related macular degeneration

📂 Article 📅 2012 🏛 Canadian Ophthalmological Society 🌐 English ⚖ 251 KB